First Page | Document Content | |
---|---|---|
![]() Date: 2013-04-24 09:31:53Coagulation system Anatomy Hemarthrosis Coagulation Factor VIII Factor VII Desmopressin Bleeding Synovectomy Haemophilia Medicine Blood | Source URL: www1.wfh.orgDownload Document from Source WebsiteFile Size: 295,84 KBShare Document on Facebook |
![]() | REGULAR ARTICLE CD4 T cells specific for factor VIII are present at high frequency in healthy donors and comprise na¨ıve and memory cells ´ ` 1DocID: 1tX4g - View Document |
![]() | News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web SitesDocID: 1qHpD - View Document |
![]() | For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [AntihaemoDocID: 1oCE0 - View Document |
![]() | 13308 FT Factor VIII Plasma déficientDocID: 1odr2 - View Document |
![]() | UPDATE: Baxalta’s BAX 855 Pivotal Data Published in Blood Shows Potential to Provide Strong Bleed Prevention with Twice Weekly Dosing for Patients with Hemophilia A •DocID: 1kAcN - View Document |